Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Schmid

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|June 1, 1979
Biologic and antineoplastic effects of enzyme-mediated in vivo depletion of L-glutamine, L-tryptophan, and L-histidineJ Roberts, F A Schmid, H J Rosenfeld
Cancer Chemotherapy Reports|April 1, 1971
Quinazoline antifolates: dosage schedules and toxicityD J Hutchison, M Shimoyama, F A Schmid
Cancer Research|March 1, 1980
Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustardF A Schmid, G M Otter, C C Stock
Cancer Research|January 1, 1985
Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agentsF A Schmid, G M Otter, B M Mehta
Journal of Medicinal Chemistry|August 1, 1985
Stereoselective antitumor properties in the Lewis lung carcinoma model using bis(morpholinomethyl) derivatives of tricyclic bis(dioxopiperazines)D T Witiak, B K Trivedi, F A Schmid
Cancer Research|February 1, 1993
Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumorsF M Sirotnak, G M Otter, F A Schmid
Cancer Treatment Reports|May 1, 1977
Comparative antitumor effects of peptichemio and other alkylating agentsF A Schmid, S E Banks, C C Stock
Journal of Medicinal Chemistry|September 1, 1985
Synthesis and antimetastatic properties of stereoisomeric tricyclic bis(dioxopiperazines) in the Lewis lung carcinoma modelD T Witiak, R V Nair, F A Schmid
Cancer Research|September 1, 1986
Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 linesF A Schmid, G M Otter, C F Chen
European Journal of Cancer & Clinical Oncology|April 1, 1985
Further evaluation of bimolane and analogs as potential antitumor agentsY F Ren, G M Otter, F A Schmid
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|June 1, 1979
Biologic and antineoplastic effects of enzyme-mediated in vivo depletion of L-glutamine, L-tryptophan, and L-histidineJ Roberts, F A Schmid, H J Rosenfeld
Cancer Chemotherapy Reports|April 1, 1971
Quinazoline antifolates: dosage schedules and toxicityD J Hutchison, M Shimoyama, F A Schmid
Cancer Research|March 1, 1980
Resistance patterns of Walker carcinosarcoma 256 and other rodent tumors to cyclophosphamide and L-phenylalanine mustardF A Schmid, G M Otter, C C Stock
Cancer Research|January 1, 1985
Mutagenic and chemotherapeutic activity in L1210 leukemia of several monofunctional alkylating agentsF A Schmid, G M Otter, B M Mehta
Journal of Medicinal Chemistry|August 1, 1985
Stereoselective antitumor properties in the Lewis lung carcinoma model using bis(morpholinomethyl) derivatives of tricyclic bis(dioxopiperazines)D T Witiak, B K Trivedi, F A Schmid
Cancer Research|February 1, 1993
Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumorsF M Sirotnak, G M Otter, F A Schmid
Cancer Treatment Reports|May 1, 1977
Comparative antitumor effects of peptichemio and other alkylating agentsF A Schmid, S E Banks, C C Stock
Journal of Medicinal Chemistry|September 1, 1985
Synthesis and antimetastatic properties of stereoisomeric tricyclic bis(dioxopiperazines) in the Lewis lung carcinoma modelD T Witiak, R V Nair, F A Schmid
Cancer Research|September 1, 1986
Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 linesF A Schmid, G M Otter, C F Chen
European Journal of Cancer & Clinical Oncology|April 1, 1985
Further evaluation of bimolane and analogs as potential antitumor agentsY F Ren, G M Otter, F A Schmid
Pageof 5